Atsena Therapeutics Appoints Linda B. Couto, Ph.D., as Chief Scientific Officer
UF startup Atsena Therapeutics, a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness, announced the appointment of Linda B. Couto, Ph.D., as Chief Scientific Officer (CSO).
Cannabix: Developing a Solution for Outdated Marijuana Testing
UF startup Cannabix Technologies Inc., a Canadian company that is developing marijuana breathalyzer technology, believe their innovations will help law enforcement officers detect THC-impairment of drivers, ultimately making it easier to prosecute offenders.
Mattrix Technologies Demonstrates the World’s First WOLED Display Produced Using LCD TV Manufacturing Technology
UF startup and UF Innovate | The Hub resident Mattrix Technologies has demonstrated a new active-matrix OLED display prototype exploiting technology typically used in LCD manufacturing.
SATLANTIS Receives the Keicho Award for Innovation and Technology by CEJE
UF startup and UF Innovate | The Hub resident SATLANTIS, a Spanish business that develops Earth Observation (EO) optical payloads for small satellites around the world, received the “Keicho Award for Innovation and Technology”, within the fifth edition of the initiative by the Círculo Empresarial Japón España - CEJE (Business Circle Japan Spain), for promoting commercial relations between Spain and Japan.
Gainesville Tech Fund Selects Mattrix Technologies for Inaugural Investment
Mattrix Technologies is the first company targeted for investment by the newly established Gainesville Tech Fund, organized by venture capital firm Kirenaga. The investors in the fund include successful entrepreneurs and local business leaders.
Axogen’s Aim: Growing Tampa Into a Hub for Nerve Repair Treatment Technology
As a biotech company at the forefront of nerve repair treatment, UF startup and UF Innovate | Sid Martin Biotech alum Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, has always been near the front of the scientific curve.
Oragenics Enters into Licensing Agreement with the National Research Council of Canada, to Pursue the Rapid Development of Next-Generation SARS-CoV-2 Vaccines
UF startup and UF Innovate | Sid Martin Biotech graduate Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, announced it has entered into a licensing agreement with the National Research Council of Canada (NRC) that will enable Oragenics to pursue the rapid development of next-generation vaccines against the SARS-CoV-2 virus and its variants.
AxoGen’s Avance Nerve Graft Helps Woman Race Horses Again
Woman returns to horse racing after AxoGen's Avance nerve graft relieved her excruciating foot pain caused by osteoarthritis and surgeries.
AavantiBio and Aldevron Announce Strategic Partnership To Develop Next-Generation Gene Therapies for Rare Genetic Diseases
UF startup and UF Innovate | The Hub resident AavantiBio, a gene therapy company focused on transforming the lives of patients with rare genetic diseases, and Aldevron, a global leader in the custom development and manufacture of plasmid DNA, proteins and mRNA for the biotech industry, announced a long-term strategic partnership for the supply of plasmid DNA that will enable AavantiBio to advance its platform of innovative gene transfer therapies.
Axogen, Inc. Appoints John H. Johnson to Board of Directors
UF startup and UF Innovate | Sid Martin Biotech alum Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, announced that John H. Johnson has been appointed to its Board of Directors.
